电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant VEGFR2 (Ramucirumab Biosimilar) 抗体

This anti-VEGFR2 (Ramucirumab Biosimilar) antibody is a 小鼠 单克隆 antibody detecting VEGFR2 (Ramucirumab Biosimilar) in FACS 和 in vivo. Suitable for 人.
产品编号 ABIN7795122
发货至: 中国

Quick Overview for Recombinant VEGFR2 (Ramucirumab Biosimilar) 抗体 (ABIN7795122)

抗原

VEGFR2 (Ramucirumab Biosimilar)

抗体类型

Recombinant Antibody

适用

宿主

  • 3
  • 1
小鼠

克隆类型

  • 4
单克隆

标记

  • 3
  • 1
This VEGFR2 (Ramucirumab Biosimilar) antibody is un-conjugated

应用范围

  • 3
  • 3
  • 1
  • 1
  • 1
Flow Cytometry (FACS), In vivo Studies (in vivo)

质量等级

Research Grade
  • Expression System

    Mammalian cells

    原理

    Ramucirumab Biosimilar, Human VEGFR2 Monoclonal Antibody

    产品特性

    What is ramucirumab biosimilar research grade? Research grade Ramucirumab biosimilar uses the same protein sequences as the therapeutic antibody ramucirumab. Ramucirumab, a fully human IgG1 monoclonal antibody and a direct VEGFR2 antagonist, binds with high affinity to the extracellular domain of VEGFR2 and block the binding of natural VEGFR ligands (VEGF-A, VEGF-C and VEGF-D). These ligands are secreted by solid tumors to promote angiogenesis (formation of new blood vessels from pre-existing ones) and enhance tumor blood supply. Binding of ramucirumab to VEGFR2 leads to inhibition of VEGF-mediated tumor angiogenesis. Kinase insert domain receptor (KDR, a type IV receptor tyrosine kinase, CD309, cluster of differentiation 309, Flk1, Fetal Liver Kinase 1) is the human gene encoding vascular endothelial growth factor receptor 2 (VEGFR-2), which is a VEGF receptor. The Q472H germline KDR genetic variant affects VEGFR-2 phosphorylation and has been found to associate with microvessel density in NSCLC.

    纯化方法

    Protein A or G affinity column

    纯度

    >95 % by reducing SDS-PAGE

    内毒素水平

    < 1 EU per 1 mg of the protein by the LAL method

    免疫原

    Human VEGFR2
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    > 3 mg/mL

    储存条件

    4 °C,-20 °C

    储存方法

    Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
  • 抗原

    VEGFR2 (Ramucirumab Biosimilar)

    别名

    Ramucirumab Biosimilar

    物质类

    Biosimilar
You are here:
Chat with us!